Wuhan Hvsen Biotechnology Co.,Ltd. (SHE:300871)
China
· Delayed Price · Currency is CNY 25.38
-0.68 (-2.61%)
Mar 9, 2026, 3:04 PM CST
Wuhan Hvsen Biotechnology Market Cap
Wuhan Hvsen Biotechnology has a market cap or net worth of 5.12 billion as of March 9, 2026. Its market cap has increased by 180.84% in one year.
Market Cap
5.12B
Enterprise Value
4.94B
Revenue
1.67B
Ranking
n/a
PE Ratio
21.28
Stock Price
25.38
Market Cap Chart
Since August 24, 2020, Wuhan Hvsen Biotechnology's market cap has decreased from 6.83B to 5.12B, a decrease of -25.15%. That is a compound annual growth rate of -5.10%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ChemPartner PharmaTech | 5.18B |
| Hangzhou Biotest Biotech | 5.41B |
| Beijing Bohui Innovation Biotechnology Group | 5.06B |
| Jiangsu Bioperfectus Technologies | 5.01B |
| Assure Tech (Hangzhou) | 4.98B |
| PharmaResources (Shanghai) | 5.64B |
| Shanghai Obio Technology (Group) Corp. | 4.86B |
| Pulike Biological Engineering | 4.73B |